Selected research
Market Structure
Global Morphine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Morphine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Morphine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Morphine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Morphine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Morphine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Morphine include Sun Pharmaceutical Industries, Qinghai Pharmaceutical, Northeast Pharmaceutical Group, Sanofi Winthrop Industrie, Purdue Pharma, Mallinckrodt Pharmaceuticals, Macfarlan Smith and Alcaliber, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Morphine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Morphine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Morphine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Morphine market size, projected growth trends, production technologies, key applications, and end-use industries.
Morphine Segment by Company
Sun Pharmaceutical Industries
Qinghai Pharmaceutical
Northeast Pharmaceutical Group
Sanofi Winthrop Industrie
Purdue Pharma
Mallinckrodt Pharmaceuticals
Macfarlan Smith
Alcaliber
Morphine Segment by Type
Injection
Oral Tablets
Capsule
Others
Morphine Segment by Application
Diarrhea Suppressant
Cough Suppressant
Anesthesia
Morphine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Morphine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Morphine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Morphine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Morphine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Morphine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Morphine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Morphine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Oral Tablets
- Capsule
- Others
Applications
- Diarrhea Suppressant
- Cough Suppressant
- Anesthesia
Companies covered
- Sun Pharmaceutical Industries
- Qinghai Pharmaceutical
- Northeast Pharmaceutical Group
- Sanofi Winthrop Industrie
- Purdue Pharma
- Mallinckrodt Pharmaceuticals
- Macfarlan Smith
- Alcaliber
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Morphine Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Morphine Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Morphine Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Morphine Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Morphine Market Dynamics
- 2.1 Morphine Industry Trends
- 2.2 Morphine Industry Drivers
- 2.3 Morphine Industry Opportunities and Challenges
- 2.4 Morphine Industry Restraints
3 Morphine Market by Manufacturers
- 3.1 Global Morphine Revenue by Manufacturers (2021-2026)
- 3.2 Global Morphine Sales by Manufacturers (2021-2026)
- 3.3 Global Morphine Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Morphine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Morphine Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Morphine Manufacturers, Product Type & Application
- 3.7 Global Morphine Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Morphine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Morphine Players Market Share by Revenue in 2025
- 3.8.3 2025 Morphine Tier 1, Tier 2, and Tier 3
4 Morphine Market by Type
- 4.1 Morphine Type Introduction
- 4.1.1 Injection
- 4.1.2 Oral Tablets
- 4.1.3 Capsule
- 4.1.4 Others
- 4.2 Global Morphine Sales by Type
- 4.2.1 Global Morphine Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Morphine Sales by Type (2021-2032)
- 4.2.3 Global Morphine Sales Market Share by Type (2021-2032)
- 4.3 Global Morphine Revenue by Type
- 4.3.1 Global Morphine Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Morphine Revenue by Type (2021-2032)
- 4.3.3 Global Morphine Revenue Market Share by Type (2021-2032)
5 Morphine Market by Application
- 5.1 Morphine Application Introduction
- 5.1.1 Diarrhea Suppressant
- 5.1.2 Cough Suppressant
- 5.1.3 Anesthesia
- 5.2 Global Morphine Sales by Application
- 5.2.1 Global Morphine Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Morphine Sales by Application (2021-2032)
- 5.2.3 Global Morphine Sales Market Share by Application (2021-2032)
- 5.3 Global Morphine Revenue by Application
- 5.3.1 Global Morphine Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Morphine Revenue by Application (2021-2032)
- 5.3.3 Global Morphine Revenue Market Share by Application (2021-2032)
6 Global Morphine Sales by Region
- 6.1 Global Morphine Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Morphine Sales by Region (2021-2032)
- 6.2.1 Global Morphine Sales by Region (2021-2026)
- 6.2.2 Global Morphine Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Morphine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Morphine Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Morphine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Morphine Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Morphine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Morphine Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Morphine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Morphine Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Morphine Revenue by Region
- 7.1 Global Morphine Revenue by Region
- 7.1.1 Global Morphine Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Morphine Revenue by Region (2021-2026)
- 7.1.3 Global Morphine Revenue by Region (2027-2032)
- 7.1.4 Global Morphine Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Morphine Revenue (2021-2032)
- 7.2.2 North America Morphine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Morphine Revenue (2021-2032)
- 7.3.2 Europe Morphine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Morphine Revenue (2021-2032)
- 7.4.2 Asia-Pacific Morphine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Morphine Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Morphine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sun Pharmaceutical Industries
- 8.1.1 Sun Pharmaceutical Industries Company Information
- 8.1.2 Sun Pharmaceutical Industries Business Overview
- 8.1.3 Sun Pharmaceutical Industries Morphine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sun Pharmaceutical Industries Morphine Product Portfolio
- 8.1.5 Sun Pharmaceutical Industries Recent Developments
- 8.2 Qinghai Pharmaceutical
- 8.2.1 Qinghai Pharmaceutical Company Information
- 8.2.2 Qinghai Pharmaceutical Business Overview
- 8.2.3 Qinghai Pharmaceutical Morphine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Qinghai Pharmaceutical Morphine Product Portfolio
- 8.2.5 Qinghai Pharmaceutical Recent Developments
- 8.3 Northeast Pharmaceutical Group
- 8.3.1 Northeast Pharmaceutical Group Company Information
- 8.3.2 Northeast Pharmaceutical Group Business Overview
- 8.3.3 Northeast Pharmaceutical Group Morphine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Northeast Pharmaceutical Group Morphine Product Portfolio
- 8.3.5 Northeast Pharmaceutical Group Recent Developments
- 8.4 Sanofi Winthrop Industrie
- 8.4.1 Sanofi Winthrop Industrie Company Information
- 8.4.2 Sanofi Winthrop Industrie Business Overview
- 8.4.3 Sanofi Winthrop Industrie Morphine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Sanofi Winthrop Industrie Morphine Product Portfolio
- 8.4.5 Sanofi Winthrop Industrie Recent Developments
- 8.5 Purdue Pharma
- 8.5.1 Purdue Pharma Company Information
- 8.5.2 Purdue Pharma Business Overview
- 8.5.3 Purdue Pharma Morphine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Purdue Pharma Morphine Product Portfolio
- 8.5.5 Purdue Pharma Recent Developments
- 8.6 Mallinckrodt Pharmaceuticals
- 8.6.1 Mallinckrodt Pharmaceuticals Company Information
- 8.6.2 Mallinckrodt Pharmaceuticals Business Overview
- 8.6.3 Mallinckrodt Pharmaceuticals Morphine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Mallinckrodt Pharmaceuticals Morphine Product Portfolio
- 8.6.5 Mallinckrodt Pharmaceuticals Recent Developments
- 8.7 Macfarlan Smith
- 8.7.1 Macfarlan Smith Company Information
- 8.7.2 Macfarlan Smith Business Overview
- 8.7.3 Macfarlan Smith Morphine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Macfarlan Smith Morphine Product Portfolio
- 8.7.5 Macfarlan Smith Recent Developments
- 8.8 Alcaliber
- 8.8.1 Alcaliber Company Information
- 8.8.2 Alcaliber Business Overview
- 8.8.3 Alcaliber Morphine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Alcaliber Morphine Product Portfolio
- 8.8.5 Alcaliber Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Morphine Value Chain Analysis
- 9.1.1 Morphine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Morphine Production Mode & Process
- 9.2 Morphine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Morphine Distributors
- 9.2.3 Morphine Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst